Found 11 matching trials
Effect of Indacaterol on Inspiratory Capacity (IC) PHASE3 This study is being conducted to assess the effect of indacaterol (150 μg o...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease PHASE3 This study will assess the efficacy, tolerability and safety of NVA237 comp...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Observational Study of Adherence to LABA / LAMA in Chronic Obstructive Pulmonary Disease (COPD) N/A The objective of the study is to observe the effect of adherence to once-da...
Show More Location
CTMS MIGRATION CENTER representing all obvious CTMS Dummy Sites
Learn More & Join Trial
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease PHASE3 The study is intended to characterize the lung function profile of BI1744 i...
Show More Location
1222.39.32003 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Co-administration of Olodaterol Respimat® and Tiotropium Handihaler® PHASE3 The overall objective of this study is to assess efficacy and safety of 12 ...
Show More Location
1222.52.02090 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese Patients PHASE3 This is a 52-week, multi-center, randomized, open label, parallel group stu...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Co-administration of Olodaterol Respimat® and Tiotropium Handihaler® PHASE3 The overall objective of this study is to assess efficacy and safety of 12 ...
Show More Location
1222.51.01055 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients PHASE3 This trial evaluates the rate of onset of bronchodilator action of aclidini...
Show More Location
Respiratory Clinical Trials Ltd
Learn More & Join Trial
Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD) PHASE2 The safety, tolerability, pharmacokinetics and pharmacodynamics/efficacy pr...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Spiriva® 18µg Once Daily in Chinese COPD Patients of Different Disease Severities N/A The objective of the present Post Marketing Surveillance Study (PMS) study ...
Show More Location
Multiple Locations
Learn More & Join Trial